Relationship between genetic polymorphisms and adverse reaction of antihypertensive drugs in patients with essential hypertension

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-RCH-12002864

Enrollment

Unknown

Registered

2012-12-24

Start date

2008-03-16

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

control group:no

hypertension group :antihypertensive drugs

Eligibility

Sex/Gender

Male

Age

18 Years to 79 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with primary hypertension,having mean systolic blood pressure >=140 mmHg and =90mmHg and <110 mmHg without antihypertensive therapy.

Exclusion criteria

Exclusion criteria: Secondary hypertension; pregnant or lactating were excluded from this study

Design outcomes

Primary

Measure	Time frame
Blood pressure;	—

Countries

China

Contacts

Public ContactWei Zhang

yjsd2003@163.com+86 0731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026